AACR’s culture of collaboration and ingenuity fuels scientific breakthroughs.
AACR conferences and journals showcase scientific discovery poised to make a clinical impact, and AACR journals welcome new editors.
Dr. McCormick’s work clarifying how KRAS mutations alter RAS signaling helped lay the foundation for the first targeted therapies against this common cancer driver.
AACR Program cochairs Dr. Paul S. Mischel and Dr. Alice T. Shaw highlight key themes of the AACR Annual Meeting 2026.
Cancer survivors, researchers, and patient advocates call on the nation’s policymakers to make research funding a priority.
The inaugural AACR Pediatric Cancer Progress Report maps out research advances that have increased survival for kids with cancer and the challenges that still remain.
The AACR’s publicly accessible cancer registry of real-word genomic and clinical data celebrates milestone.
Party with a Purpose proceeds advance melanoma research, Fanconi Cancer Foundation becomes grant partner, and two-day summit spotlights research from AACR grantees.
Corporations, patient advocacy groups, and other benefactors help the AACR in large and small ways.
A rare cancer survivor works to raise research funding, and a daughter runs the Marine Corps Marathon in father’s honor.
AACR continues to engage the community to back cancer research.
Former AACR Foundation Chief Philanthropic Officer and Vice-President of Development reflects over his time at the AACR with pride.